• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

EXENATIDE

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

NFKB1 LACTATE DEHYDROGENASE PD-1 COVID-19 SARS-COV-2 IMMUNITY ALBUMIN IMMUNE RESPONSE LISTERIA MONOCYTOGENES INSULIN ESCHERICHIA COLI ANGIOTENSIN II IL1B CANDIDA ALBICANS STAPHYLOCOCCUS AUREUS MYALGIA AGING AUTOPHAGY ACE2 IL2 CELL DIFFERENTIATION CELL PROLIFERATION IL6 TNF COAGULATION APOPTOTIC PROCESS IFNG INFLAMMATION PSEUDOMONAS AERUGINOSA CASP3 ACE ALZHEIMER'S DISEASE INFLAMMATORY RESPONSE METFORMIN TMPRSS2 NEUTROPHILS INTERFERON RHEUMATOID ARTHRITIS CD4 IL10 HELICOBACTER PYLORI CANCER COGNITION RAS PARKINSON DISEASE

© 2021 Biovista Vizit All Rights Reserved.